Novavax shares gained more than 29% after the $350 million deal with Canada.

Novavax shares (NVAX) soared over 29% on Monday after the Canadian government agreed to pay the biotech firm nearly $350 million to cancel supplies of some previously ordered COVID-19 vaccines. The company said in a regulatory filing that both parties filed an amendment to the agreement struck in January 2021. The updated agreement called for […]